Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Ross Stores, Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Ross Stores, Inc. trades at $226 (market cap $72.05B). The key difference: Ross Stores, Inc. is far larger — about 15.3× Definium Therapeutics Inc. Common Shares's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Ross Stores, Inc. for 48 Days on average.
| DFTX | ROST | |
|---|---|---|
Market Cap | $4.71B | $72.05B |
Volume | 1,966,636 | 1,674,861 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $255.23 |
52-Week Low | $10.68 | $147.71 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $3.67B | $72.50B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ross Stores (ROST) trades at $225.53, up 0.59% today, with a bearish technical signal but strong fundamental performance. The stock shows robust profitability with a net income margin of 10.85% and ROE of 42.63%, supported by consistent earnings beats in recent quarters. Revenue growth trends upward, reaching $21.13B in 2025, while analyst consensus remains bullish with a $274.14 price target. Recent news highlights store expansion and value-focused strategies attracting shoppers amid competitive retail pressures.
The outlook for ROST is positive based on earnings momentum and strategic initiatives, though technical indicators suggest near-term caution. Risks include rising costs and market volatility, but institutional buying and high ROE provide support. The stock offers growth potential if execution on expansion continues, with downside cushioned by strong cash flow and analyst optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
